Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Taxane-based combinations as adjuvant chemotherapy of early breast cancer: a meta-analysis of randomized trials 3. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer 4. 2008 Exclusive Survey—Earnings: Good news for primary care income 5. Paclitaxel plus bevacizumab versus paclitaxel alone for metastatic breast cancer
Top Ten Searches
post partum incontinence fibroid hpv colpotomy ovarian cyst curettage endometriosis intrauterine umbilical cordYour Article Summary
See Latest ArticlesBioidentical Hormones: Ethics and Misinformed Consent
The Female Patient, 07/31/09
Rosenthal S – The ethical use of BHRT revolves around re–educating the patient as part of the informed consent process. When prescribing hormone therapy to an appropriate candidate, the clinician has an obligation to first explain that there is no scientific evidence to support that bioidentical hormones are “identical” to human hormones. Correcting this false perception is important, because if left uncorrected, the claim suggests that BHRT carries no risks. All patients should be counseled about the differences between oral and transdermal therapies, as well as the difference between a progestin (eg, medroxyprogesterone acetate) and progesterone. The established risks, benefits, and costs of each must be explained, and clinicians should be mindful about being professionally influenced by any particular pharmaceutical company.presumption of misinformation should begin all clinical consultations with perimenopausal patients who request, or are assessed for, hormone therapy, while a “new normal” of setting aside time for correcting misinformation should become part of the consent process.
Related Articles
Issues in postmenopausal hormone therapy: A 3-part CME newsletter series Counseling patients about bioidentical hormone preparations
Sexuality, Reproduction & Menopause, 11/13/09
Relevance Score: 70%
Issues in postmenopausal hormone therapy: depression, endometrial health, and discontinuation
Sexuality, Reproduction & Menopause, 10/09/09
Relevance Score: 68%
Colorectal cancer incidence and postmenopausal hormone use by type, recency, and duration in cancer prevention study II
Cancer Epidemiology, Biomarkers & Prevention, 10/28/09
Relevance Score: 46%
Depressive tendency in children with growth hormone deficiency
Journal of Paediatrics and Child Health, 10/23/09
Relevance Score: 46%
Activational effects of sex hormones on cognition in men
Clinical Endocrinology, 10/16/09
Relevance Score: 46%
Today in Clinical Pharmacology...keeping you current
Receive free subspecialty "5-minute updates" via email
Prognosis of women with metastatic breast cancer by HER2 status and trastuzumab treatment: An institutional-based review
Journal of Clinical Oncology, 11/30/09
Bevacizumab in the treatment of breast cancer
Cancer Treatment Reviews, 11/30/09
Review of the safety, efficacy, costs and patient acceptability of recombinant follicle-stimulating hormone for injection in assisting ovulation induction in infertile women
International Journal of Women's Health, 11/30/09
Sponsor
Article Search
Sponsor